Stage I: initially every six months, then annually if stable

Stage II, III, IV: initially every three to six months, monitor indefinitely

Serious extrapulmonary involvement: monitor indefinitely

Monitor three years after cessation of therapy for potential relapse, subsequent follow-up not necessary if stable